MAINZ BIOMED NV (MYNZ)
NL0015000LC2 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -26.30M | -26.39M | -11.69M | -590.00K | -960.00K | |||
| Depreciation Amortization | 866.41K | 380.00K | 70.00K | 60.00K | 50.00K | |||
| Change In Working Capital | -64.63K | 1.39M | -140.00K | 60.00K | 420.00K | |||
| Interest Paid | 153.58K | 130.00K | 50.00K | 160.00K | 160.00K | |||
| Other non cash items | 3.56M | 9.85M | 8.54M | 0.00 | 60.00K | |||
| OPERATING CASH FLOW | -21.94M | -14.77M | -3.22M | -470.00K | -420.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.90M | -660.00K | -20.00K | -10.00K | 0.00 | |||
| Other Investing Activity | N/A | N/A | 1.22M | N/A | N/A | |||
| INVESTING CASH FLOW | -1.90M | -660.00K | 1.20M | -10.00K | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 8.77M | -300.00K | -60.00K | 0.00 | 420.00K | |||
| Stock Issued/Repurchased | 6.39M | 24.25M | 10.43M | N/A | N/A | |||
| Other Financing Activity | -933.75K | 0.00 | 240.00K | 400.00K | 0.00 | |||
| FINANCING CASH FLOW | 14.23M | 23.94M | 10.61M | 400.00K | 420.00K | |||
| Exchange Rate Effect | -459.86K | -100.00K | 10.00K | 0.00 | -30.00K | |||
| CHANGE IN CASH | -10.07M | 8.41M | 8.60M | -80.00K | -30.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -21.94M | -14.77M | -3.22M | -470.00K | -420.00K | |||
| Capital Expenditure | -1.90M | -660.00K | -20.00K | -10.00K | 0.00 | |||
| FREE CASH FLOW | -23.84M | -15.43M | -3.24M | -480.00K | -420.00K | |||
All data in USD